Thanks. So it’s important to know when the 26th gets included and expected follow up from the time of 26th starting in trial to estimate conservative time frame. Median duration of gem/nab paclitaxel in the original Mpact trial was 4 months. So if we use that assumption, and ATX saying mid- year for results, let’s say June 30, working back 4 months means 26th should have been enrolled end Feb.
However if they get lucky and all 6 + objective responses they need to pass futility occur in first handful of patients, that’s great!
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-40
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
-0.005(6.85%) |
Mkt cap ! $18.46M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.3¢ | 6.8¢ | $10.78K | 154.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16129 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 21334 | 1 |
View Market Depth
| Last trade - 15.59pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
-0.005 ( 5.56 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.1¢ | 6.8¢ | 10032 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| ATX (ASX) Chart |